AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04171427 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Lithium liposome
Description: Cosmetic product
Study NCT04171427 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Placebo
Description: Cosmetic product vehicle
Study NCT03304496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitroglycerin 100 MCG/ML Injectable Solution
Description: Previously described.
Study NCT03304496 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline Solution
Description: Previously described.
Study NCT04064567 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PrEP-LINK
Description: CHW will assist with healthcare and social service navigation and will utilize adherence counseling techniques. As per the model our intervention is based upon (the national Transitions Clinic Network \[TCN\]), our CHW has a history of incarceration. Participants randomized to the intervention group, the CHW will assist individuals with employment, housing (if needed), referrals to mental health or substance use treatment, keeping track of medical appointments and medication adherence.
Study NCT04064567 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Standard of Care
Description: Participants will receive education about PrEP and referral to a community PrEP provider which exceeds the standards of care these individuals would otherwise receive.
Study NCT00393640 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Early and regular breast milk expression
Description: Breast pump given to be used on regular intervals
Study NCT04626466 — intervention group
Intervention type: OTHER
Intervention: Biological investigations
Description: (complete blood count, platelet count, renal function evaluation)
Study NCT03465423 — intervention group
Intervention type: PROCEDURE
Intervention: Not applicable (measuring subject's effect site concentration of propofol during the induction of general anesthesia)
Description: The patients of two cohort group will undergo general anesthesia in the same way and therefore there is no intervention in this study.
Study NCT01670227 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: PARENTCORPS
Description: ParentCorps is a culturally-informed, universal intervention (for all children enrolled in Pre-K within an elementary school) designed to promote positive behavioral supports for children at home and in the classroom. ParentCorps includes two complementary components: 1) parent and child group intervention (13 2-hour sessions after school) for Pre-K students and their families; 2) professional development and individual consultation for early childhood teachers.
Study NCT01670227 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PARENTCORPS
Description: ParentCorps is a culturally-informed, universal intervention (for all children enrolled in Pre-K within an elementary school) designed to promote positive behavioral supports for children at home and in the classroom. ParentCorps includes two complementary components: 1) parent and child group intervention (13 2-hour sessions after school) for Pre-K students and their families; 2) professional development and individual consultation for early childhood teachers.
Study NCT01307280 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: RCT1
Description: the bookHEALTH manual and eHEALTH tools, the basic Internet component of the intervention
Study NCT01307280 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: RCT2
Description: bookHEALTH and an interactive version of eHEALTH that provided tailored computerized feedback whenever participants submitted weekly assessments
Study NCT01307280 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: RCT3
Description: bookHEALTH, the interactive version of eHEALTH, and telephonic coaching support provided by trained health lifestyle coaches every 2 weeks alternating between a telephone call (typically 15 to 20 minutes) and a personalized e-mail. The coaches used motivational interviewing, helped participants solve problems, and reinforced their successes.
Study NCT02166151 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omalizimab
Description: Omalizimab 150 mg S.C. once a month for consecutive 3 months
Study NCT03877263 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Endocervical swab for detection of STI
Description: After we collect the samples, they will be evaluated using the Hologic APTIMA Chlamydia trachomatis and Neisseria gonorrhoeae assays.
Study NCT06259630 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine
Description: Participant receives oral dose of nicotine
Study NCT06259630 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo oral capsule
Description: Participant receives oral dose of placebo
Study NCT06259630 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral capsule
Description: Participant receives oral dose of placebo
Study NCT01442051 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acute Normovolemic Hemodilution
Description: A predetermined volume of whole blood will be removed from these patients based on an established protocol. Crystalloid and colloid will then be infused to replace intravascular volume based on this protocol. Patients will be closely monitored intraoperatively with serum arterial hemoglobin (HgB) levels drawn hourly. Patients will be transfused with autologous blood if HgB \< 7.0 g/dL. If the volume of autologous blood has not been transfused within eight hours or by the completion of the procedure, the remainder will be transfused at that time. If the volume of autologous blood has been transfused and the patients require additional blood transfusions (HgB \<7g.dL), allogenic blood will be transfused thereafter. These transfusion triggers are based on common intraoperative practice patterns. Patients may also be transfused intraoperatively at any time for a HgB ≥ 7.0 g/dL based on the judgment of the attending anesthesiologist or surgeon but the reason will be recorded.
Study NCT05088551 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patient Education
Description: The education was divided into three parts. The information in the first part of the booklet (general information, preoperative preparation, and operation day) is given in the preoperative period. In the postoperative period, the patients were visited and the information in the second part (postoperative hospital stay, first, second, and third-day goals after surgery) was given. Before the patients were discharged, the information in the third section (things to be considered in the recovery process at home) was presented. According to the physical conditions of the clinic, patient education was carried out in an area suitable for teaching as much as possible.
Study NCT01004510 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: zoledronic acid
Description: Zoledronic acid (Zometa) 4mg IV every 4 weeks for 3 treatments with chemotherapy as selected by treating physician
Study NCT02527213 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium thiosulfate
Description: Additional treatment(s) due to lesion progression When intervention occurs, the date of the intervening event should be recorded in the source documents and the (CRF). The subject should continue in the study as scheduled.
Study NCT02527213 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Additional treatment(s) due to lesion progression When intervention occurs, the date of the intervening event should be recorded in the source documents and the (CRF). The subject should continue in the study as scheduled.
Study NCT01624272 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Threshold® Inspiratory Muscle Trainer (Respironics® Health Scan Inc. Cedar Grove, NJ, USA).
Description: Interval-based program consisting of seven cycles of 2-minutes work and 1-minute rest. The sessions took place 5 times per week over a six-week period for a total of 30 sessions. All participants were familiarized with the breathing exercises over a two-day familiarization period at the beginning of the protocol.
Study NCT01624272 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yoga Pranayama breathing exercises
Description: Interval-based program. The sessions took place 5 times per week over a six-week period for a total of 30 sessions. All participants were familiarized with the breathing exercises over a two-day familiarization period at the beginning of the protocol.
Study NCT02112123 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Icariin
Study NCT02112123 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Matching placebo
Study NCT00851305 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endomicroscope (Pentax, Tokyo, Japan)
Description: A Pentax EC3870K endomicroscope which can produce conventional white light endoscopic images and confocal images at the same time with a optical slice thickness of 7 μm, a lateral resolution of 0.7 μm, a scanning depth of 0 to 250 μm, a pixel density of 1024×512 pixels (at an image acquisition rate of 1.6 frames/second)，and a field of view of 475 μm×475 μm.
Study NCT00851305 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Gastroscopes (Pentax, Tokyo, Japan)
Description: Conventional white light gastroscopes (Pentax EG-2940 gastroscopes)
Study NCT01524874 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D3
Description: 10,000 IU per Day for 12 Weeks
Study NCT01924247 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Outpatient secondary prevention program
Description: The comprehensive outpatient program is designed to last for 12 weeks. Participants are treated in groups of 8 or less. Every week there are two days with therapeutic and educational sessions, once with two hours of physical exercise therapy and once with 45 minutes of aerobic ergometer training and one hour of lecture and counseling. On the day with the two hours of physical therapy one of the sessions includes aerobic ergometer training or Nordic walking, and the other session focuses on improvements of fine motor skills, coordination, balance, mobilization, stretching, weight training or breathing. The lectures include three lectures on etiology, diagnosis, treatment and prevention of stroke by a neurologist, one on vascular risk factors by a cardiologist, five on nutrition counseling by nutritionists, two on active and passive smoking cessation and one lecture on psychological coping strategies given by a neuropsychologist.
Study NCT01924247 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Standard treatment by family physician
Description: Standard treatment by family physician.
Study NCT00983996 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alendronate Sodium Tablets, 10 mg
Description: 10 mg, single-dose fasting
Study NCT00983996 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fosamax Tablets, 10 mg
Description: 10 mg, single-dose fasting
Study NCT01706757 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: go-cart
Description: conducts exercises with the help of a go-cart
Study NCT03032536 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AL-3778
Description: AL-3778 tablets or capsules
Study NCT03032536 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Entecavir
Description: Entecavir once daily for 14 days
Study NCT03032536 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Entecavir
Description: Entecavir once daily for 14 days
Study NCT03032536 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tenofovir disoproxil fumarate
Description: Tenofovir disoproxil fumarate once daily for 14 days
Study NCT03032536 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate
Description: Tenofovir disoproxil fumarate once daily for 14 days
Study NCT03227939 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy（LSG）
Description: LSG：All these operations were performed by the same surgeon team. Dissect the greater omentum alongside the greater gastric curvature, make sure that the greater gastric curvature and fundus of stomach were completely made free from pancreas and spleen.Fully Exposed left and right diaphragm angle and taking care not to injure the esophagus. Resection was started 2 to 4 cm from pylorus and alongside a 40Fr tube up to the esophagogastric junction and created a 60 to 80ml gastric lumen, removed the fundus of stomach thoroughly and take care of the esophagus and preventriculus. Repaired the hiatal hernia if it was exsit.
Study NCT03227939 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic sleeve gastrectomy（LSG）
Description: LSG：All these operations were performed by the same surgeon team. Dissect the greater omentum alongside the greater gastric curvature, make sure that the greater gastric curvature and fundus of stomach were completely made free from pancreas and spleen.Fully Exposed left and right diaphragm angle and taking care not to injure the esophagus. Resection was started 2 to 4 cm from pylorus and alongside a 40Fr tube up to the esophagogastric junction and created a 60 to 80ml gastric lumen, removed the fundus of stomach thoroughly and take care of the esophagus and preventriculus. Repaired the hiatal hernia if it was exsit.
Study NCT03227939 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Uvulopalatopharyngoplasty(UPPP) and Adenoidectomy/Tonsillectomy
Description: UPPP：PPP is typically administered to patients with obstructive sleep apnea in isolation. It is administered as a stand-alone procedure in the hope that the tissue which obstructs the patient's airway is localized in the back of the throat. The rationale is that, by removing the tissue, the patient's airway will be wider and breathing will become easier.
Study NCT03285438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Reduced dose of DOAC
Description: The patient will receive apixaban 2.5 mg twice daily or rivaroxaban 10 mg once daily during a mean follow-up period of 36 months (12 to 65 months)
Study NCT03285438 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Full dose of DOAC
Description: The patient will receive apixaban 5 mg twice daily or Rivaroxaban 20 mg once daily during a mean follow-up period of 36 months (12 to 65 months)
Study NCT03306277 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Onasemnogene Abeparvovec-xioi
Description: Non-replicating recombinant adeno-associated virus serotype 9 (AAV9) containing the complimentary deoxyribonucleic acid (cDNA) of the human SMN gene under the control of the cytomegalovirus (CMV) enhancer/chicken-β-actin-hybrid promoter (CB). The AAV inverted terminal repeat (ITR) has been modified to promote intramolecular annealing of the transgene, thus forming a double-stranded transgene ready for transcription.
Study NCT03858933 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: eBrainFit Platform
Description: Alpha/Theta regulation with eyes open
Study NCT03858933 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: eBrainFit Platform
Description: Amygdala regulation with eyes open
Study NCT02878148 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Diagnostic imaging modalities for suspected renal colic
Description: All patients with suspected acute uncomplicated renal colic included will undergo ultrasonography in addition to unenhanced CT of pelvis and abdomen and plain X-ray of the abdomen.~Imaging examination will be performed according to current guidelines.~Ultrasonography study and colour doppler will include the kidney, ureterovesical joint and ureters. Unenhanced CT will be performed using a dedicated low-dose protocol.
Study NCT01929187 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Phytonail
Study NCT01929187 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Loceryl
Study NCT02895802 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Verbal instructions with picture diagram
Description: verbal instructions and picture diagram
Study NCT02895802 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Verbal instructions with video of ADSC
Description: Verbal instructions and watching video depicting ADSC
Study NCT02895802 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: verbal instructions w. video of w/o DS
Description: verbal instructions and watching video depicting person without DS washing her hands
Study NCT02895802 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: verbal instructions w. video w/DS
Description: verbal instructions and watching video depicting person with DS washing his hands
Study NCT00592579 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2-methoxyestradiol
Description: 800 mg of 2ME2 (capsules) administered orally every 12 hours for a total daily dose of 1600 mg.
Study NCT02293928 — intervention group
Intervention type: PROCEDURE
Intervention: Hybrid coronary revascularization
Description: Hybrid coronary revascularization with standard double antiplatelet therapy
Study NCT03877263 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Vaginal swab for detection of STI
Description: After we collect the samples, they will be evaluated using the Hologic APTIMA Chlamydia trachomatis and Neisseria gonorrhoeae assays.~We will then compare the results from a vaginal vs. endocervical specimens within and between the groups
Study NCT01722136 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low Dosage
Description: Exercise dose of 8kcal/kg/week
Study NCT01722136 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High Dosage
Description: Exercise dose of 14kcal/kg/week
Study NCT03666910 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Audiometer
Description: detection of hearing problems
Study NCT04118582 — intervention group
Intervention type: OTHER
Intervention: Body composition and resting metabolic rate analisys
Study NCT04260373 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C]SHR4640
Description: Patients will receive single dose of orally \[14C\]SHR4640 on Day 1.
Study NCT02986555 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Existing Biofeedback
Description: Using relaxing assisted biofeedback approach
Study NCT02986555 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Biofeedback accompanied with virtual reality
Description: Using relaxation approach with existing biofeedback accompanied by virtual reality relaxation
Study NCT04020796 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Beetroot juice
Description: Thirty-seven hypertension, with age 40-70 years were randomized to receive a 500ml volume of beetroot juice contains 11.5 mmol of inorganic nitrate or mineral water in a single moment.
Study NCT04020796 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Beetroot juice
Description: Thirty-seven hypertension, with age 40-70 years were randomized to receive a 500ml volume of beetroot juice contains 11.5 mmol of inorganic nitrate or mineral water in a single moment.
Study NCT03296956 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Motherwell
Description: The interventions involves a dietary supplement called Motherwell, at current stage, to reduce the intensity of sadness in day-5 postpartum women.
Study NCT03296956 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo for appearance, taste
Study NCT01939535 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Evaluation of an imaging technique ic MRI
Study NCT00728351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vildagliptin + metformin
Study NCT00728351 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: metformin
Description: 1000 bid metformin
Study NCT01694563 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Synergy Ablation System
Description: Patient will undergo an elective open cardiac surgical procedure to be performed on cardiopulmonary bypass for one or more of the following:~* Coronary Artery Bypass Grafting (CABG)~* Mitral valve repair or replacement~* Aortic valve repair or replacement~* Tricuspid valve repair or replacement The aim of the treatment is a complete bi-atrial Maze IV procedure which includes pulmonary vein isolation coupled with lesions made on both the left and right atria.
Study NCT00687206 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valsartan 160mg plus HCT 25mg
Description: valsartan 160 mg once a day for 6 months plus hydrochlorothiazide 25 mg a tablet once a day for 6 months
Study NCT03573544 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OBI-888
Description: For the dose-escalation phase, OBI-888 will be given weekly at the dose levels of 5, 10, and 20 mg/kg.
Study NCT03573544 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OBI-888
Description: For the dose-expansion phase, OBI-888 will be given weekly at 20 mg/kg dose level.
Study NCT03573544 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Globo H IHC Assay
Description: This assay will be used to identify eligible patients who may clinically benefit from the OBI-888 treatment, defined by Globo H expression.
Study NCT04542746 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Minimally invasive surgical technique
Description: After local anesthesia , for the sites of test group , a minimally invasive surgical technique (MIST) will be performed. The defects associated inter-dental papilla will be surgically approached with a diagonal incision following the pattern of the simplified papilla preservation flap. Flap elevation was to the buccal and oral aspect in the interdental space, An enamel matrix derivative (EMD) was applied into the defect.f A primary closure of the interdental papillae will be achieved using a 5-0 monofilament non resorbable suturing material.